Multiple Sclerosis Discovery Forum
  News and Future Directions
  Papers
  Forums
  Professional Resources
  Research Resources
MSGene - Polymorphism Details
Back Search Methods Disclaimer Credits
 Study: IMSGC, 2010
 Gene: PTGER4  (EP4; EP4R; MGC126583)  Entrez Gene
 Protein: prostaglandin E receptor 4 (subtype EP4)  (PGE receptor EP4 subtype; PGE receptor, EP4 subtype; PGE2 receptor EP4 subtype; prostaglandin E2 receptor EP4 subtype; prostanoid EP4 receptor)  ProteinLink
 Chromosome: 5   (View: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  X  Y  MT)
 Status: Updated 31 January 2011
Meta-Analysis     Gene Overview
Total number of polymorphisms investigated by this study: 1

Case-Control Studies (by ethnic group)
  Genotypes*
Polymorphism ID#
(Link to NCBI)
Population   A-Allele C-Allele A/A
(frequency)
A/C
(frequency)
C/C
(frequency)
 Caucasian
rs6896969 UK-1 (discovery) MS
CTR
0.38
0.41
0.62
0.59
119 (0.143)
175 (0.170)
391 (0.471)
499 (0.484)
320 (0.386)
356 (0.346)
rs6896969 USA-1 (discovery) MS
CTR
0.38
0.39
0.62
0.61
198 (0.143)
168 (0.155)
650 (0.470)
518 (0.477)
535 (0.387)
400 (0.368)
rs6896969 Italy MS
CTR
0.38
0.39
0.62
0.61
119 (0.143)
99 (0.154)
391 (0.471)
306 (0.477)
320 (0.386)
237 (0.369)
rs6896969 UK-2 MS
CTR
0.41
0.40
0.59
0.60
100 (0.169)
120 (0.160)
286 (0.484)
360 (0.481)
205 (0.347)
269 (0.359)
rs6896969 USA-2 MS
CTR
0.38
0.40
0.62
0.60
87 (0.142)
86 (0.160)
288 (0.471)
257 (0.479)
237 (0.387)
193 (0.360)
*Genotypes have been calculated from allele frequencies assuming Hardy-Weinberg equilibrium.
Print this page
Email this page
MSDF RSS

Text size
Share & Bookmark
MSGene Recent Updates
MSGene Top Results
Top Results Details
1. HLA-DRB1
2. IL2RA
3. IL7R
4. TAGAP
5. CLEC16A
6. EVI5
7. GWA_16q24.1
8. GWA_5p13.1
9. TTC34
10. AHI1   
[see more]
MSGene Stats
Studies: 789
Genes: 809
Polymorphisms: 2907
Meta-analyses: 324
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Copyright © 2024 Biomedical Research Forum LLC Disclaimer Copyright